Emergency anthrax treatment study aims to save lives in a crisis
NCT ID NCT03569553
Summary
This study will evaluate the safety and effectiveness of a treatment called AIGIV for people who develop inhalational anthrax during a major exposure event, like a bioterror attack. It will only be activated if such an event occurs. Researchers will collect information on patient survival, illness severity, and how the drug behaves in the body to understand if it helps control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INHALATIONAL ANTHRAX are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.